ACM
ONCT

ADAR1 Capital Management’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

ADAR1 Capital Management’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,472
Closed -$22.2K – 329
2024
Q1 		$22.2K Buy
+2,472
New +$21.7K 0.01% 215

Other funds holding ONCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PPW
Pasadena Private Wealth Pasadena, California $723M AUM 18.72% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return

ADAR1 Capital Management's ONCT Position: Q2 2024 in Review

ADAR1 Capital Management sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q2 2024, closing a stake of 2,472 shares — an estimated $22.2K sold.

ADAR1 Capital Management first reported a position in ONCT in Q1 2024 and held it in 1 quarter. The position peaked at $22.2K in Q1 2024. 26 funds tracked by Wall St. Rank hold ONCT as of Q2 2024.

  • ADAR1 Capital Management reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • ADAR1 Capital Management sold 2,472 Oncternal Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $22.2K.
  • ADAR1 Capital Management first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
  • ADAR1 Capital Management's Oncternal Therapeutics, Inc. Common Stock position peaked at $22.2K in Q1 2024.
  • 26 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q2 2024.

Based on ADAR1 Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.